Could SARS-CoV-2-induced lung injury be attenuated by vitamin D?

Autor: Dezhi Mu, Yi Qu, Xihong Li, Dongqiong Xiao, Xiaojuan Su
Rok vydání: 2021
Předmět:
0301 basic medicine
ARDS
ALI
acute lung injury

viruses
medicine.disease_cause
Renin-Angiotensin System
Pathogenesis
0302 clinical medicine
Ang I
angiotensin I

Acute lung injury
Medicine
030212 general & internal medicine
Vitamin D
skin and connective tissue diseases
Receptor
Coronavirus
TGF-β
transforming growth factor β

Respiratory Distress Syndrome
TNF-α
tumour necrosis factor alpha

Ang1-7
angiotensin 1-7

RBM
receptor-binding motif

Type-II Pneumocytes
VDREs
vitamin D responsive elements

virus diseases
General Medicine
respiratory system
HBDs
β‐defensins

Infectious Diseases
Perspective
IL-8
inerleukin-8

VDR
vitamin D receptor

Ang1-9
angiotensin 1-9

Angiotensin-Converting Enzyme 2
hormones
hormone substitutes
and hormone antagonists

Microbiology (medical)
030106 microbiology
Lung injury
CCL3
chemokine (C-C motif) ligand 3

IFN-α
interferon alpha

SARS-CoV
SARS coronavirus

lcsh:Infectious and parasitic diseases
hACE2
human ACE2

RBD
receptor binding domain

03 medical and health sciences
Renin–angiotensin system
ACE2
angiotensin converting enzyme-2

Vitamin D and neurology
Humans
lcsh:RC109-216
Ang Ⅱ
angiotensin Ⅱ

ARDS
acute respiratory distress syndrome

AP-1
activation protein 1

SARS-CoV-2
business.industry
fungi
COVID-19
RAS
renin-angiotensin system

medicine.disease
respiratory tract diseases
2019-nCoV
novel coronavirus

Immunology
RSV
respiratory syncytial virus

business
Zdroj: International Journal of Infectious Diseases, Vol 102, Iss, Pp 196-202 (2021)
International Journal of Infectious Diseases
ISSN: 1201-9712
DOI: 10.1016/j.ijid.2020.10.059
Popis: Highlights • As a counter-regulatory arm of the renin-angiotensin system (RAS), ACE2 plays critical roles in the pathogenesis of ARDS and acute lung injury. • The affinity of the spike protein receptor binding domain (RBD) of the SARS-CoV-2 with human ACE2 (hACE2) largely determines the degree of clinical symptoms infected by SARS-CoV-2. • Vitamin D was found to affect ACE2, the same target of SARS-CoV-2, we therefore propose that vitamin D might alleviate ARDS and acute lung injury induced by SARS-CoV-2 through modulating ACE2.
A novel coronavirus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) has been confirmed to have the capacity to transmit from humans to humans, causing acute respiratory distress syndrome (ARDS) and acute lung injury. Angiotensin converting enzyme-2 (ACE2) has been found to be expressed on type II pneumocytes. As a counterregulatory arm of the renin-angiotensin system (RAS), ACE2 plays critical roles in the pathogenesis of ARDS and acute lung injury. The affinity of the spike protein receptor binding domain (RBD) of SARS-CoV-2 with human ACE2 (hACE2) largely determines the degree of clinical symptoms after infection by SARS-CoV-2. Previous studies have revealed that regulating the ACE2/RAS system was effective in the treatment of severe acute respiratory syndrome coronavirus (SARS-CoV)-induced ARDS and acute lung injury. Since ACE2 is the host cell receptor of both SARS-CoV-2 and SARS-CoV, regulating the ACE2/RAS system may alleviate ARDS and acute lung injury caused by SARS-CoV-2 as well as SARS-CoV. Vitamin D was found to affect ACE2, the target of SARS-CoV-2; therefore, we propose that vitamin D might alleviate ARDS and acute lung injury induced by SARS-CoV-2 by modulating ACE2.
Databáze: OpenAIRE